Zimbabwe has rejected a substantial US healthcare agreement worth 367 million US dollars (£272m) spanning five years because of the United States' request for sensitive data.
The decision became public after a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
An official representative later stated that the United States was demanding access to biological samples for research and profit while was unwilling to guarantee the benefits from future vaccines.
"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged continued dialogue to find a deal acceptable to both sides so the nation's vital HIV treatment initiative can proceed.
Broader Background
Zimbabwe's decision follows a similar case in Kenya, where a court suspended a similar deal with the US following legal challenges were filed about the safety of citizens' health data.
Since resuming office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had managed aid for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance transparency and accountability.
As per reports, Sixteen nations in Africa have to date agreed to these new health pacts, representing more than $18.3bn in committed funds.
Specifics of the Declined Agreement
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration might have yielded extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to share its biological resources and data for a long time, with no equivalent assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"In essence, our country would provide the raw materials for medical research without any certainty that the end products would be accessible to our people if a new pandemic arise."
National Interest and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting systems previously established through the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.
"This mechanism is intended to guarantee that when a country provides its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
These objections regarding the US deal "are not meant as opposition to America," he added.
"We are open to further discussions with our American counterparts on how subsequent collaboration could be structured in a manner that honours the sovereignty and interests of each country."
Health Experts Response
Medical experts stated it acknowledged the government's concerns, but urged that talks should continue since much of the country's HIV programmes were funded by foreign aid.
"In cases where technical issues arise, such as those involving information security or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," it commented.
This impasse highlights the continuing challenges between accepting vital international aid and safeguarding national sovereignty in an ever more interconnected world.